1. Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21.
   Roberta Santarelli et al, 2021, IUBMB Life CrossRef
2. Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression.
   Christos Kontos, 0 CrossRef
3. The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression
   Sayantan Banik et al, 2021, J Breast Cancer CrossRef
4. MMP-9 reinforces radiation-induced delayed invasion and metastasis of neuroblastoma cells through second-signaling positive feedback with NFκB via both ERK and IKK activation
   Dinesh Babu Somasundaram et al, 2021, Cell Biol Toxicol CrossRef
5. Prochlorperazine enhances radiosensitivity of non-small cell lung carcinoma by stabilizing GDP-bound mutant KRAS conformation
   Kirti Sad et al, 2021, Free Radical Biology and Medicine CrossRef
6. Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity
   Rasha A. Hassan et al, 2021, Bioorganic Chemistry CrossRef
7. Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma
   Sukanya Roy et al, 2021, Cells CrossRef
8. Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer
   Jennifer J. Lee et al, 2021, IJMS CrossRef
9. Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells
   Sumaiah S. Al-Asmari et al, 2022, Front. Cell Dev. Biol. CrossRef
10. Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers
    Peng Xu et al, 2022, Front. Oncol. CrossRef
11. Dimerization of the Peptide CXCR4-Antagonist on Macromolecular and Supramolecular Protraction Arms Affords Increased Potency and Enhanced Plasma Stability
    Mirja Harms et al, 2022, Bioconjugate Chem. CrossRef
12. Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment
    Shadi Vesagh Hamedani et al, 2022, Progress in Biophysics and Molecular Biology CrossRef
13. PDE4D binds and interacts with YAP to cooperatively promote HCC progression
    Huili Ren et al, 2022, Cancer Letters CrossRef
14. USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma.
    Hong-Beom Park et al, 2022, Cell Death Dis CrossRef
15. Corema album Leaves Mediate DNA Damage in Triple-Negative Breast Cancer Cells
    Ana Sofia Cerquido et al, 2022, CIMB CrossRef
16. CK2 and the Hallmarks of Cancer
    May-Britt Firnau et al, 2022, Biomedicines CrossRef
17. Tumor vessel co-option: The past & the future
    Anne Cuypers et al, 2022, Front. Oncol. CrossRef
18. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses
    Shahab Mahmoudvand et al, 2022, Infect Agents Cancer CrossRef
19. Consequences of aberrated DNA methylation in Colon Adenocarcinoma: a bioinformatic-based multi-approach
    Arash Moradi et al, 2022, BMC Genom Data CrossRef
20. New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia
    Ahmed K. Hamdy et al, 2022, Pharmaceuticals CrossRef
21. Substance P is overexpressed in cervical squamous cell carcinoma and promoted proliferation and invasion of cervical cancer cells in vitro
    Ying Wang et al, 2023, Eur J Histochem CrossRef
22. The Essential Oil from Conyza bonariensis (L.) Cronquist (Asteraceae) Exerts an In Vitro Antimelanoma Effect by Inducing Apoptosis and Modulating the MAPKs, NF-κB, and PKB/AKT Signaling Pathways
    Rafael Carlos Ferreira et al, 2023, Pharmaceuticals CrossRef
23. Adjuvant Effect of Cinnamon Polyphenolic Components in Colorectal Cancer Cell Lines
    Alessandro Palmioli et al, 2023, IJMS CrossRef
24. Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways
    Soon Park et al, 2023, Oncol Lett CrossRef
25. Inhibitory Effects of 5-Fluorouracil on the Growth of 4-Hydroxytamoxifen-Resistant and Sensitive Breast Cancer Cells
    Danila Vladimirovich Sorokin et al, 2023 CrossRef
26. l‐Methionine potentiates anticancer activity of Sorafenib by epigenetically altering DUSP3/ERK pathway in hepatocellular carcinoma
    Swagata Pal et al, 2024, J Biochem & Molecular Tox CrossRef
27. Pharmacological and therapeutic potentials of cordycepin in hematological malignancies
    Zahra Taghinejad et al, 2023, Biochemical and Biophysical Research Communications CrossRef
28. Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS‐STING‐IFNβ‐HLA
    Ye Yi et al, 2024, Advanced Science CrossRef
29. Integrative analysis of metabolomics and proteomics reveals mechanism of berberrubine-induced nephrotoxicity
    Jinqiu Rao et al, 2024, Toxicology and Applied Pharmacology CrossRef
30. Imidazo[1,2‐a]Quinoxaline‐2‐Carbonitrile Derivative (RA‐22) Inhibits Self‐Renewal and Growth of Cancer Stem and Cancer Cells via Downregulating AKT Pathway
    Pramit Kumar et al, 2024, ChemistrySelect CrossRef
31. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer
    Maria George Elias et al, 2024, Cancers CrossRef
32. Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells
    Maria George Elias et al, 2024, IJMS CrossRef
33. A Selective Histone Deacetylase 6 Inhibitor Showed Antiviral Activity Against Dengue and Zika Viruses
    Hao-Wen Shih et al, 2023 CrossRef
34. The potential role of targeting the leptin receptor as a treatment for breast cancer in the context of hyperleptinemia: a literature review
    Abbas S. Neamah et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
35. Evaluation of CacyBP/SIP expression and its relationship with ERK1/2 and p38 kinase in testicular seminoma
    Grzegorz Młynarczyk et al, 2024, Pathology - Research and Practice CrossRef
36. Gene-knockdown Methods for Silencing Nuclear-localized Insulin Receptors in Lung Adenocarcinoma Cells: A Bioinformatics Approach
    Qiu Ren et al, 2025, CG CrossRef
37. Beta‐Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF‐κB Pathways
    Hui‐Wen Chan et al, 2024, Phytotherapy Research CrossRef
38. Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
    Sumedha Gupta et al, 2025, Neuroscience CrossRef